Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)
ArchivedNational Institutes of Health
Description
The National Institute on Drug Abuse [NIDA] seeks research proposals to identify the effects of anti-retroviral therapy (ART) used for the treatment of HIV/AIDS on neuronal and glial structure and function, particularly when occurring in a background of chronic exposure to an abused drug (including opioids, cocaine and stimulants, cannabinoids, and nicotine). The overall goal is to determine the contributions of antiretroviral [ARV] treatment regimens that are used to suppress viral load in the neurological and neurocognitive deficits that are associated with HIV-Associated Neurocognitive Disorders [HAND].
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>grantsinfo@nih.gov
grantsinfo@nih.gov
- PostedJun 23, 2021
- ClosesFeb 2, 2022
- Program funding$3,000,000
- CFDA93.279
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro